Literature DB >> 29708908

Anteverting Bernese periacetabular osteotomy in the treatment of neurogenic hip dysplasia in cerebral palsy.

Andrew G Georgiadis1,2, Vivek Dutt1, Walter H Truong1,2, Susan A Novotny1, Tom F Novacheck1,2.   

Abstract

All patients with hypertonic cerebral palsy undergoing Bernese periacetabular osteotomy (PAO) between 2005 and 2014 were reviewed. Clinical and radiographic parameters, including the cerebral palsy hip classification and anterior and posterior wall indices were collected to assess acetabular reorientation. Twenty (83%) of 24 procedures involved the correction of posterolateral acetabular insufficiency and were 'anteverting PAOs'. All 20 experienced improvements in radiographic indices. Eleven (58%) of 19 PAOs in ambulatory patients were performed in the setting of other multilevel orthopedic surgery. The anteverting PAO is successful in correcting the posterolateral acetabular insufficiency present in spastic hip dysplasia, and can be performed in conjunction with a single-event multilevel surgery.

Entities:  

Mesh:

Year:  2018        PMID: 29708908     DOI: 10.1097/BPB.0000000000000513

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  2 in total

1.  Does the Rule of Thirds Adequately Detect Deficient and Excessive Acetabular Coverage?

Authors:  Vera M Stetzelberger; Angela M Moosmann; Guoyan Zheng; Joseph M Schwab; Simon D Steppacher; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

2.  Derotational Subtrochanteric Osteotomy and External Fixation for the Treatment of Neurogenic Hip Dislocation in Children with Cerebral Palsy: Could This Be a Viable Method of Treatment?

Authors:  Stavros Angelis; Georgios Vynichakis; Angelos Trellopoulos; Alexandros Apostolopoulos; Dimitrios Filippou; Marios Salmas; Michail Chandrinos; Theodore Balfousias; Leonidas Palaiodimos; Niki Kyriazi; John Michelarakis
Journal:  Cureus       Date:  2020-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.